Moderna vets help launch new RNA venture with $300M in largest financing round of 2023 so far

Moderna vets help launch new RNA venture with $300M in largest financing round of 2023 so far

Source: 
Fierce Biotech
snippet: 

ReNAgade Therapeutics unveiled Tuesday after closing a $300 million series A, fueled by the promise of RNA technology and a leadership team made up of Moderna vets. And it’s jumping out of the gate with about 100 employees and a new collaboration.